Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | BRCA1 | P38398 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22199784 | 0.88 | KDM4E (0.41) | KDM4EATML3MBTL1ALDH1A1LMNA | |
| SCHEMBL22200033 | 0.87 | HSD17B10 (0.38) | KDM4EL3MBTL1NPC1RAB9AALDH1A1 | |
| SCHEMBL16582318 | 0.87 | HSD17B10 (0.40) | KDM4ENPC1RAB9AALDH1A1MEN1 | |
| SCHEMBL22199968 | 0.86 | L3MBTL1 (0.35) | KDM4EATML3MBTL1NPC1RAB9A | |
| SCHEMBL22200034 | 0.86 | NPC1 (0.33) | NPC1RAB9A | |
| SCHEMBL19428548 | 0.83 | KDM4E (0.32) | KDM4EATML3MBTL1ALDH1A1 | |
| SCHEMBL17660993 | 0.82 | CASP1 (0.36) | KDM4EATML3MBTL1ALDH1A1LMNA | |
| SCHEMBL22479894 | 0.82 | CASP1 (0.36) | KDM4EATML3MBTL1ALDH1A1LMNA | |
| SCHEMBL22199930 | 0.82 | MAPT (0.36) | KDM4EL3MBTL1NPC1RAB9AALDH1A1 | |
| SCHEMBL22199774 | 0.81 | MEN1 (0.37) | KDM4EL3MBTL1NPC1RAB9AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200216392-A1 | A PLURALITY OF HOST MATERIALS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | DUPONT SPECIALTY MATERIALS KOREA LTD. (KR) | 2020-07-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200216392-A1 | A PLURALITY OF HOST MATERIALS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | TERF2, PIEZO1, TERT | KDM4E 1076/4885ATM 2798/4885L3MBTL1 80/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.